Early Studies By Various Authors

On Borrelia Sp.

Embers ME, Hasenkampf NR, Jacobs MB, et al. Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to Borrelia burgdorferi by tick feeding. PLoS One. 2017;12(12):e0189071.

Maraspin V, Ogrinc K, Ružić-Sabljić E, Lotrič-Furlan S, Strle F. Isola- tion of Borrelia burgdorferi sensu lato from blood of adult patients with borrelial lymphocytoma, Lyme neuroborreliosis, Lyme arthritis and acrodermatitis chronica atrophicans. Infection. 2011;39(1):35–40. Len

ormand C, Jaulhac B, Debarbieux S, et al. Expanding the clinico- pathological spectrum of late cutaneous Lyme borreliosis (acrodermati- tis chronica atrophicans [ACA]): A prospective study of 20 culture- and/ or polymerase chain reaction (PCR)-documented cases. J Am Acad Dermatol. 2016;74(4):685–692. Rud

enko N, Golovchenko M, Vancova M, Clark K, Grubhoffer L, Oliver JH. Isolation of live Borrelia burgdorferi sensu lato spirochaetes from patients with unde ned disorders and symptoms not typical for Lyme borreliosis. Clin Microbiol Infect. 2016;22(3):267.e9–267.e15. Cla

rk KL, Leydet B, Hartman S. Lyme borreliosis in human patients in Florida and Georgia, USA. Int J Med Sci. 2013;10(7):915–931. Sap

i E, Pabbati N, Datar A, Davies EM, Rattelle A, Kuo BA. Improved culure conditions for the growth and detection of Borrelia from human serm. Int J Med Sci. 2013;10(4):362–376.

Brorson & Brorson Studies

[Borrelia burgdorferi--a unique bacterium].

Brorson Ø.

Tidsskr Nor Laegeforen. 2009 Oct 22;129(20):2114-7. doi: 10.4045/tidsskr.08.0023. Review. Norwegian. No abstract available.

~~

Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline.

Brorson Ø, Brorson SH, Scythes J, MacAllister J, Wier A, Margulis L.

Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18656-61. doi: 10.1073/pnas.0908236106. Epub 2009 Oct 20.

~~

Grapefruit seed extract is a powerful in vitro agent against motile and cystic forms of Borrelia burgdorferi sensu lato.

Brorson O, Brorson SH.

Infection. 2007 Jun;35(3):206-8. No abstract available.

~~

An in vitro study of the activity of telithromycin against mobile and cystic forms of Borreliaafzelii.

Brorson Ø, Brorson SH.

Infection. 2006 Feb;34(1):26-8.

~~

An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole.

Brorson O, Brorson SH.

Int Microbiol. 2004 Jun;7(2):139-42.

~~

An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine.

Brorson O, Brorson SH.

~~

Susceptibility of motile and cystic forms of Borrelia burgdorferi to ranitidine bismuth citrate.

Brorson O, Brorson SH.

Int Microbiol. 2001 Dec;4(4):209-15.

~~

An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole.

Brorson O, Brorson SH.

APMIS. 1999 Jun;107(6):566-76.

~~

A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes.

Brorson O, Brorson SH.

APMIS. 1998 Dec;106(12):1131-41.

~~

In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium.

Brorson O, Brorson SH.

Infection. 1998 May-Jun;26(3):144-50.

~~

Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes.

Brorson O, Brorson SH.

Infection. 1997 Jul-Aug;25(4):240-6.

Last Updated- April 2019

Lucy Barnes

AfterTheBite@gmail.com